These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27769299)

  • 1. Ex vivo piperaquine resistance developed rapidly in Plasmodium falciparum isolates in northern Cambodia compared to Thailand.
    Chaorattanakawee S; Lon C; Jongsakul K; Gawee J; Sok S; Sundrakes S; Kong N; Thamnurak C; Chann S; Chattrakarn S; Praditpol C; Buathong N; Uthaimongkol N; Smith P; Sirisopana N; Huy R; Prom S; Fukuda MM; Bethell D; Walsh DS; Lanteri C; Saunders D
    Malar J; 2016 Oct; 15(1):519. PubMed ID: 27769299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.
    Chaorattanakawee S; Saunders DL; Sea D; Chanarat N; Yingyuen K; Sundrakes S; Saingam P; Buathong N; Sriwichai S; Chann S; Se Y; Yom Y; Heng TK; Kong N; Kuntawunginn W; Tangthongchaiwiriya K; Jacob C; Takala-Harrison S; Plowe C; Lin JT; Chuor CM; Prom S; Tyner SD; Gosi P; Teja-Isavadharm P; Lon C; Lanteri CA
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4631-43. PubMed ID: 26014942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers.
    Lim P; Dek D; Try V; Eastman RT; Chy S; Sreng S; Suon S; Mao S; Sopha C; Sam B; Ashley EA; Miotto O; Dondorp AM; White NJ; Su XZ; Char MC; Anderson JM; Amaratunga C; Menard D; Fairhurst RM
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5277-83. PubMed ID: 23939897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic and genotypic characterization of Thai isolates of Plasmodium falciparum after an artemisinin resistance containment project.
    Thita T; Jadsri P; Thamkhantho J; Ruang-Areerate T; Suwandittakul N; Sitthichot N; Mahotorn K; Tan-Ariya P; Mungthin M
    Malar J; 2018 May; 17(1):197. PubMed ID: 29764451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo drug sensitivity profiles of Plasmodium falciparum field isolates from Cambodia and Thailand, 2005 to 2010, determined by a histidine-rich protein-2 assay.
    Tyner SD; Lon C; Se Y; Bethell D; Socheat D; Noedl H; Sea D; Satimai W; Schaecher K; Rutvisuttinunt W; Fukuda MM; Chaorattanakawee S; Yingyuen K; Sundrakes S; Chaichana P; Saingam P; Buathong N; Sriwichai S; Chann S; Timmermans A; Saunders DL; Walsh DS
    Malar J; 2012 Jun; 11():198. PubMed ID: 22694953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluations of candidate markers of dihydroartemisinin-piperaquine resistance in Plasmodium falciparum isolates from the China-Myanmar, Thailand-Myanmar, and Thailand-Cambodia borders.
    Ye R; Zhang Y; Zhang D
    Parasit Vectors; 2022 Apr; 15(1):130. PubMed ID: 35413937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of three anti-malarial regimens for uncomplicated Plasmodium falciparum malaria in Cambodia, 2009-2011: a randomized controlled trial and brief review.
    Lek D; Rachmat A; Harrison D; Chin G; Chaoratanakawee S; Saunders D; Menard D; Rogers WO
    Malar J; 2022 Sep; 21(1):259. PubMed ID: 36071520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct comparison of the histidine-rich protein-2 enzyme-linked immunosorbent assay (HRP-2 ELISA) and malaria SYBR green I fluorescence (MSF) drug sensitivity tests in Plasmodium falciparum reference clones and fresh ex vivo field isolates from Cambodia.
    Chaorattanakawee S; Tyner SD; Lon C; Yingyuen K; Ruttvisutinunt W; Sundrakes S; Sai-gnam P; Johnson JD; Walsh DS; Saunders DL; Lanteri CA
    Malar J; 2013 Jul; 12():239. PubMed ID: 23849006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperaquine resistant Cambodian Plasmodium falciparum clinical isolates: in vitro genotypic and phenotypic characterization.
    Boonyalai N; Vesely BA; Thamnurak C; Praditpol C; Fagnark W; Kirativanich K; Saingam P; Chaisatit C; Lertsethtakarn P; Gosi P; Kuntawunginn W; Vanachayangkul P; Spring MD; Fukuda MM; Lon C; Smith PL; Waters NC; Saunders DL; Wojnarski M
    Malar J; 2020 Jul; 19(1):269. PubMed ID: 32711538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four years' monitoring of in vitro sensitivity and candidate molecular markers of resistance of Plasmodium falciparum to artesunate-mefloquine combination in the Thai-Myanmar border.
    Phompradit P; Muhamad P; Wisedpanichkij R; Chaijaroenkul W; Na-Bangchang K
    Malar J; 2014 Jan; 13():23. PubMed ID: 24423390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Variant PfCRT Isoform Can Contribute to
    Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA
    mBio; 2017 May; 8(3):. PubMed ID: 28487425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum.
    Pascual A; Parola P; Benoit-Vical F; Simon F; Malvy D; Picot S; Delaunay P; Basset D; Maubon D; Faugère B; Ménard G; Bourgeois N; Oeuvray C; Didillon E; Rogier C; Pradines B
    Malar J; 2012 Feb; 11():45. PubMed ID: 22333675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of in vitro susceptibilities and molecular markers of resistance of Plasmodium falciparum isolates from Thai-Myanmar border to chloroquine, quinine, mefloquine and artesunate.
    Chaijaroenkul W; Wisedpanichkij R; Na-Bangchang K
    Acta Trop; 2010 Feb; 113(2):190-4. PubMed ID: 19879850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antimalarial drug susceptibility in Thai border areas from 1998-2003.
    Chaijaroenkul W; Bangchang KN; Mungthin M; Ward SA
    Malar J; 2005 Aug; 4():37. PubMed ID: 16060967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.
    Amaratunga C; Lim P; Suon S; Sreng S; Mao S; Sopha C; Sam B; Dek D; Try V; Amato R; Blessborn D; Song L; Tullo GS; Fay MP; Anderson JM; Tarning J; Fairhurst RM
    Lancet Infect Dis; 2016 Mar; 16(3):357-65. PubMed ID: 26774243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia.
    Parobek CM; Parr JB; Brazeau NF; Lon C; Chaorattanakawee S; Gosi P; Barnett EJ; Norris LD; Meshnick SR; Spring MD; Lanteri CA; Bailey JA; Saunders DL; Lin JT; Juliano JJ
    Genome Biol Evol; 2017 Jun; 9(6):1673-1686. PubMed ID: 28854635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating the Efficacy of Triple Artemisinin-Based Combination Therapies for Treating Plasmodium falciparum Malaria Patients Using Mathematical Modeling.
    Dini S; Zaloumis S; Cao P; Price RN; Fowkes FJI; van der Pluijm RW; McCaw JM; Simpson JA
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30150462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China-Myanmar border.
    Huang F; Shrestha B; Liu H; Tang LH; Zhou SS; Zhou XN; Takala-Harrison S; Ringwald P; Nyunt MM; Plowe CV
    Malar J; 2020 Sep; 19(1):334. PubMed ID: 32928233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.
    van der Pluijm RW; Imwong M; Chau NH; Hoa NT; Thuy-Nhien NT; Thanh NV; Jittamala P; Hanboonkunupakarn B; Chutasmit K; Saelow C; Runjarern R; Kaewmok W; Tripura R; Peto TJ; Yok S; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Lek D; Huy R; Dhorda M; Chotivanich K; Ashley EA; Mukaka M; Waithira N; Cheah PY; Maude RJ; Amato R; Pearson RD; Gonçalves S; Jacob CG; Hamilton WL; Fairhurst RM; Tarning J; Winterberg M; Kwiatkowski DP; Pukrittayakamee S; Hien TT; Day NP; Miotto O; White NJ; Dondorp AM
    Lancet Infect Dis; 2019 Sep; 19(9):952-961. PubMed ID: 31345710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance and in vitro susceptibility of Plasmodium falciparum in Thailand during 1988-2003.
    Suwandittakul N; Chaijaroenkul W; Harnyuttanakorn P; Mungthin M; Na Bangchang K
    Korean J Parasitol; 2009 Jun; 47(2):139-44. PubMed ID: 19488420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.